BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 206 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,000 | -93.3% | 2,077 | -91.1% | 0.00% | – |
| Q2 2023 | $746,000 | +11.2% | 23,337 | +6.4% | 0.00% | – |
| Q1 2023 | $671,000 | -31.9% | 21,929 | -12.9% | 0.00% | – |
| Q4 2022 | $985,000 | -15.7% | 25,191 | +2.5% | 0.00% | – |
| Q3 2022 | $1,169,000 | -4.1% | 24,576 | -21.9% | 0.00% | – |
| Q2 2022 | $1,219,000 | +7.6% | 31,477 | +59.1% | 0.00% | – |
| Q1 2022 | $1,133,000 | +131.7% | 19,786 | +222.5% | 0.00% | – |
| Q4 2021 | $489,000 | +201.9% | 6,136 | +229.9% | 0.00% | – |
| Q3 2021 | $162,000 | -73.2% | 1,860 | -60.5% | 0.00% | – |
| Q2 2021 | $605,000 | +99.0% | 4,708 | +23.9% | 0.00% | – |
| Q1 2021 | $304,000 | +147.2% | 3,799 | +152.1% | 0.00% | – |
| Q4 2020 | $123,000 | +12200.0% | 1,507 | +5928.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 25 | +19.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 21 | -60.4% | 0.00% | – |
| Q1 2020 | $1,000 | – | 53 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |